The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Liquid Biopsy Products-Global Market Insights and Sales Trends 2025
Synopsis
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
The global Liquid Biopsy Products market size is expected to reach US$ 8549.7 million by 2029, growing at a CAGR of 25.5% from 2023 to 2029. The market is mainly driven by the significant applications of Liquid Biopsy Products in various end use industries. The expanding demands from the Blood Sample, Urine Sample and Other Bio Fluids,, are propelling Liquid Biopsy Products market. CTCs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ctDNA segment is estimated at % CAGR for the next seven-year period.
The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Liquid Biopsy Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Liquid Biopsy Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Liquid Biopsy Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Liquid Biopsy Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Liquid Biopsy Products covered in this report include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics and Cynvenio, etc.
The global Liquid Biopsy Products market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Global Liquid Biopsy Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liquid Biopsy Products market, Segment by Type:
CTCs
ctDNA
Exosomes
Global Liquid Biopsy Products market, by Application
Blood Sample
Urine Sample
Other Bio Fluids
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Liquid Biopsy Products companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
The global Liquid Biopsy Products market size is expected to reach US$ 8549.7 million by 2029, growing at a CAGR of 25.5% from 2023 to 2029. The market is mainly driven by the significant applications of Liquid Biopsy Products in various end use industries. The expanding demands from the Blood Sample, Urine Sample and Other Bio Fluids,, are propelling Liquid Biopsy Products market. CTCs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ctDNA segment is estimated at % CAGR for the next seven-year period.
The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Liquid Biopsy Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Liquid Biopsy Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Liquid Biopsy Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Liquid Biopsy Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Liquid Biopsy Products covered in this report include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics and Cynvenio, etc.
The global Liquid Biopsy Products market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Global Liquid Biopsy Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liquid Biopsy Products market, Segment by Type:
CTCs
ctDNA
Exosomes
Global Liquid Biopsy Products market, by Application
Blood Sample
Urine Sample
Other Bio Fluids
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Liquid Biopsy Products companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Liquid Biopsy Products
1.1 Liquid Biopsy Products Market Overview
1.1.1 Liquid Biopsy Products Product Scope
1.1.2 Liquid Biopsy Products Market Status and Outlook
1.2 Global Liquid Biopsy Products Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Liquid Biopsy Products Market Size by Region (2018-2029)
1.4 Global Liquid Biopsy Products Historic Market Size by Region (2018-2023)
1.5 Global Liquid Biopsy Products Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Liquid Biopsy Products Market Size (2018-2029)
1.6.1 North America Liquid Biopsy Products Market Size (2018-2029)
1.6.2 Europe Liquid Biopsy Products Market Size (2018-2029)
1.6.3 Asia-Pacific Liquid Biopsy Products Market Size (2018-2029)
1.6.4 Latin America Liquid Biopsy Products Market Size (2018-2029)
1.6.5 Middle East & Africa Liquid Biopsy Products Market Size (2018-2029)
2 Liquid Biopsy Products Market by Type
2.1 Introduction
2.1.1 CTCs
2.1.2 ctDNA
2.1.3 Exosomes
2.2 Global Liquid Biopsy Products Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Liquid Biopsy Products Historic Market Size by Type (2018-2023)
2.2.2 Global Liquid Biopsy Products Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Liquid Biopsy Products Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Liquid Biopsy Products Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Liquid Biopsy Products Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Liquid Biopsy Products Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Liquid Biopsy Products Revenue Breakdown by Type (2018-2029)
3 Liquid Biopsy Products Market Overview by Application
3.1 Introduction
3.1.1 Blood Sample
3.1.2 Urine Sample
3.1.3 Other Bio Fluids
3.2 Global Liquid Biopsy Products Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Liquid Biopsy Products Historic Market Size by Application (2018-2023)
3.2.2 Global Liquid Biopsy Products Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Liquid Biopsy Products Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Liquid Biopsy Products Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Liquid Biopsy Products Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Liquid Biopsy Products Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Liquid Biopsy Products Revenue Breakdown by Application (2018-2029)
4 Liquid Biopsy Products Competition Analysis by Players
4.1 Global Liquid Biopsy Products Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liquid Biopsy Products as of 2022)
4.3 Date of Key Players Enter into Liquid Biopsy Products Market
4.4 Global Top Players Liquid Biopsy Products Headquarters and Area Served
4.5 Key Players Liquid Biopsy Products Product Solution and Service
4.6 Competitive Status
4.6.1 Liquid Biopsy Products Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 RainDanceTechnologies
5.1.1 RainDanceTechnologies Profile
5.1.2 RainDanceTechnologies Main Business
5.1.3 RainDanceTechnologies Liquid Biopsy Products Products, Services and Solutions
5.1.4 RainDanceTechnologies Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.1.5 RainDanceTechnologies Recent Developments
5.2 Biocartis
5.2.1 Biocartis Profile
5.2.2 Biocartis Main Business
5.2.3 Biocartis Liquid Biopsy Products Products, Services and Solutions
5.2.4 Biocartis Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.2.5 Biocartis Recent Developments
5.3 Qiagen
5.3.1 Qiagen Profile
5.3.2 Qiagen Main Business
5.3.3 Qiagen Liquid Biopsy Products Products, Services and Solutions
5.3.4 Qiagen Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.3.5 Guardant Health Recent Developments
5.4 Guardant Health
5.4.1 Guardant Health Profile
5.4.2 Guardant Health Main Business
5.4.3 Guardant Health Liquid Biopsy Products Products, Services and Solutions
5.4.4 Guardant Health Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.4.5 Guardant Health Recent Developments
5.5 MDxHealth
5.5.1 MDxHealth Profile
5.5.2 MDxHealth Main Business
5.5.3 MDxHealth Liquid Biopsy Products Products, Services and Solutions
5.5.4 MDxHealth Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.5.5 MDxHealth Recent Developments
5.6 Pathway Genomics
5.6.1 Pathway Genomics Profile
5.6.2 Pathway Genomics Main Business
5.6.3 Pathway Genomics Liquid Biopsy Products Products, Services and Solutions
5.6.4 Pathway Genomics Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.6.5 Pathway Genomics Recent Developments
5.7 NeoGenomics Laboraories
5.7.1 NeoGenomics Laboraories Profile
5.7.2 NeoGenomics Laboraories Main Business
5.7.3 NeoGenomics Laboraories Liquid Biopsy Products Products, Services and Solutions
5.7.4 NeoGenomics Laboraories Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.7.5 NeoGenomics Laboraories Recent Developments
5.8 Sysmex Inostics
5.8.1 Sysmex Inostics Profile
5.8.2 Sysmex Inostics Main Business
5.8.3 Sysmex Inostics Liquid Biopsy Products Products, Services and Solutions
5.8.4 Sysmex Inostics Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.8.5 Sysmex Inostics Recent Developments
5.9 Cynvenio
5.9.1 Cynvenio Profile
5.9.2 Cynvenio Main Business
5.9.3 Cynvenio Liquid Biopsy Products Products, Services and Solutions
5.9.4 Cynvenio Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.9.5 Cynvenio Recent Developments
5.10 Menarini Silicon Biosystems
5.10.1 Menarini Silicon Biosystems Profile
5.10.2 Menarini Silicon Biosystems Main Business
5.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Products, Services and Solutions
5.10.4 Menarini Silicon Biosystems Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.10.5 Menarini Silicon Biosystems Recent Developments
5.11 Adaptive Biotechnologies
5.11.1 Adaptive Biotechnologies Profile
5.11.2 Adaptive Biotechnologies Main Business
5.11.3 Adaptive Biotechnologies Liquid Biopsy Products Products, Services and Solutions
5.11.4 Adaptive Biotechnologies Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.11.5 Adaptive Biotechnologies Recent Developments
5.12 Biocept
5.12.1 Biocept Profile
5.12.2 Biocept Main Business
5.12.3 Biocept Liquid Biopsy Products Products, Services and Solutions
5.12.4 Biocept Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.12.5 Biocept Recent Developments
5.13 Angle plc
5.13.1 Angle plc Profile
5.13.2 Angle plc Main Business
5.13.3 Angle plc Liquid Biopsy Products Products, Services and Solutions
5.13.4 Angle plc Liquid Biopsy Products Revenue (US$ Million) & (2018-2023)
5.13.5 Angle plc Recent Developments
6 North America
6.1 North America Liquid Biopsy Products Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Liquid Biopsy Products Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Products Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Liquid Biopsy Products Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Products Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Liquid Biopsy Products Market Dynamics
11.1 Liquid Biopsy Products Industry Trends
11.2 Liquid Biopsy Products Market Drivers
11.3 Liquid Biopsy Products Market Challenges
11.4 Liquid Biopsy Products Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
